🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the China Extension study is to assess the safety and effica...
Status
Completed
Location
Beijing Cancer Hospital (0601)
Start Date
2020-07-14
Trial ID
NCT04889118
Treatments Being Tested
This is a single arm, nonrandomized, single center clinical study to invest...
Status
Unknown
Location
Hai-Tao Zhao
Start Date
2021-10-01
Trial ID
NCT05048017
Treatments Being Tested
This study consists of several parts: dose escalation, dose expansion, dose...
Status
Completed
Location
University of California at San Francisco ( Site 0004)
Start Date
2018-07-11
Trial ID
NCT03564691
Treatments Being Tested
This is a parallel assigned, open-label, perspective trial studying the saf...
Status
Unknown
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2022-05-20
Trial ID
NCT05339581
This study will assess the safety, tolerability, pharmacokinetics (PK), and...
Status
Completed
Location
Banner MD Anderson Cancer Center ( Site 0013)
Start Date
2017-07-02
Trial ID
NCT03179436
Treatments Being Tested
This study will assess the efficacy and safety of pembrolizumab plus enzalu...
Status
Completed
Location
Peking University First Hospital ( Site 0800)
Start Date
2021-05-25
Trial ID
NCT04934722
Treatments Being Tested
In this China extension study, carboplatin and paclitaxel with or without p...
Status
Completed
Location
Zhongshan Hospital Fudan University
Start Date
2017-04-21
Trial ID
NCT03875092
Treatments Being Tested
In the China extension study, Chinese participants with programmed cell dea...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-01
Trial ID
NCT03850444
Treatments Being Tested
This is a study of pembrolizumab (MK-3475) with or without lenvatinib (E708...
Status
Completed
Location
Anhui Cancer Hospital-Radiology Department ( Site 3333)
Start Date
2020-10-30
Trial ID
NCT05523323
Treatments Being Tested
The goal of this China extension study is to evaluate the efficacy and safe...
Status
Active Not Recruiting
Location
Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000)
Start Date
2022-07-27
Trial ID
NCT05899049
Treatments Being Tested